| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | | | |
| | |
|
| |
|
A refrigeration unit that supplies cold water used to cool MRI components. Depending on the system configuration chillers are used to cool shield coolers, shim coils and sometimes the air conditioning. | | | | • View the DATABASE results for 'Chiller' (2).
| | | | Further Reading: | News & More:
|
|
| | | |
|
| |
|
'Next generation MRI system 1.5T CHORUS developed by ISOL Technology is optimized for both clinical diagnostic imaging and for research development.
CHORUS offers the complete range of feature oriented advanced imaging techniques- for both clinical routine and research. The compact short bore magnet, the patient friendly design and the gradient technology make the innovation to new degree of perfection in magnetic resonance.'
Device Information and Specification
CLINICAL APPLICATION
Whole body
Spin Echo, Gradient Echo, Fast Spin Echo,
Inversion Recovery ( STIR, Fluid Attenuated Inversion Recovery), FLASH, FISP, PSIF, Turbo Flash ( MPRAGE ),TOF MR Angiography, Standard echo planar imaging package (SE-EPI, GE-EPI), Optional:
Advanced P.A. Imaging Package (up to 4 ch.), Advanced echo planar imaging package,
Single Shot and Diffusion Weighted EPI, IR/FLAIR EPI
STRENGTH
20 mT/m (Upto 27 mT/m)
| | | | • View the DATABASE results for 'CHORUS 1.5T™' (2).
| | | | | | | | | |
|
| |
| (Cr(III)-labeled RBC's) Chromium labeled red blood cells have paramagnetic properties and potential as an intravascular MRI contrast agent. The labeling with chromium decreases the relaxation times of packed red blood cells (RBCs). The use of RBCs in nuclear medicine suggests a low toxicity.
See also Contrast Agents, Intravascular Contrast Agents, Blood Pool Agents. | | | | • View the DATABASE results for 'Chromium Labeled Red Blood Cells' (2).
| | | | Further Reading: | Basics:
|
|
| | | |
|
| |
| The main problem with paramagnetic heavy metal ions in their native form is their toxicity. Complexation of
the metal ion with organic ligand, while considerably
decreasing toxicity, may alter paramagnetic properties of
the metal. Chromium-EDTA complex was the first such agent tried,
but problems with synthesis and long-term stability
prevented its clinical application. | | | | | | | | | | | | |
| | |
|
| |
| Look Ups |
| |